NEW Nephros DkBlueRGB.png
Nephros Announces Results for Quarter Ended September 30, 2023
08 nov. 2023 16h15 HE | Nephros, Inc.
Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from...
NEW Nephros DkBlueRGB.png
Nephros Announces Preliminary Results for First Quarter 2023
04 avr. 2023 07h30 HE | Nephros, Inc.
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...
NEW Nephros DkBlueRGB.png
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022
11 janv. 2023 07h30 HE | Nephros, Inc.
Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;Active Customer Sites Continue to Climb SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
neph.jpg
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
31 janv. 2020 07h30 HE | Nephros, Inc.
SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that develops and sells high performance...
66663_NephrosLogo.jpg
Nephros Appoints Oliver Spandow to its Board of Directors
13 août 2018 07h30 HE | Nephros, Inc.
Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device...
66663_NephrosLogo.jpg
Nephros to Present at 8th Annual LD Micro Invitational
04 juin 2018 07h45 HE | Nephros, Inc.
SOUTH ORANGE, NJ, June 04, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...
66663_NephrosLogo.jpg
Nephros Announces $2.9 Million Private Placement
11 avr. 2018 07h30 HE | Nephros, Inc.
SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...
NEW Nephros DkBlueRGB.png
Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
26 févr. 2018 08h10 HE | Nephros, Inc.
SOUTH ORANGE, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...